It is thought to help reduce oxidative stress and improve complexion
Managing patients who do not achieve glycemic goals despite uptitration of basal insulin provides a particular challenge, with a number of available options
Most GLP-1 agonists come in injector pens that can be used by patients at home
Clinician oversight: Safe, personalized care throughout treatment
Other non-invasive serial monitoring tests to assess changes in liver function are being investigated, including the methacetin breath test and HepQuant.[48], [49] Safety Drug induced liver injury and other toxicity signals will make an otherwise viable therapeutic agent untenable and this needs to be determined as early in development as possible
U100: 0.1 = 10 (1 = 100 ), 225 mcg: 225 5000 /1 = 0.045 = 4.5 263 mcg: 263 5000 /1 = 0.052 = 5.3 300 mcg: 300 5000 /1 = 0.06 = 6 338 mcg: 338 5000 /1 = 0.068 = 6.8 375 mcg: 375 5000 /1 = 0.075 = 7.5 413 mcg: 413 5000 /1 = 0.083 = 8.3 450 mcg: 450 5000 /1 = 0.09 = 9 488 mcg: 488 5000 /1 = 0.098 = 9.8 525 mcg: 525 5000 /1 = 0.105 = 10.5 563 mcg: 563 5000 /1 = 0.113 = 11.3